Published in Arch Biochem Biophys on November 18, 2014
Targeting Acidity in Pancreatic Adenocarcinoma: Multispectral Optoacoustic Tomography Detects pH-Low Insertion Peptide Probes In Vivo. Clin Cancer Res (2015) 0.94
Residue-specific structures and membrane locations of pH-low insertion peptide by solid-state nuclear magnetic resonance. Nat Commun (2015) 0.75
Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem (2000) 19.03
X-ray structure of a protein-conducting channel. Nature (2003) 9.20
Structure of bacteriorhodopsin at 1.55 A resolution. J Mol Biol (1999) 8.17
Micellar nanocarriers: pharmaceutical perspectives. Pharm Res (2006) 4.21
Helical membrane protein folding, stability, and evolution. Annu Rev Biochem (2000) 3.63
Solving the membrane protein folding problem. Nature (2005) 2.96
Acidity generated by the tumor microenvironment drives local invasion. Cancer Res (2013) 2.63
Mechanism and uses of a membrane peptide that targets tumors and other acidic tissues in vivo. Proc Natl Acad Sci U S A (2007) 2.45
Translocation of molecules into cells by pH-dependent insertion of a transmembrane helix. Proc Natl Acad Sci U S A (2006) 2.36
A novel technology for the imaging of acidic prostate tumors by positron emission tomography. Cancer Res (2009) 2.30
A method for assessing the stability of a membrane protein. Biochemistry (1997) 2.14
Spontaneous, pH-dependent membrane insertion of a transbilayer alpha-helix. Biochemistry (1997) 2.11
A monomeric membrane peptide that lives in three worlds: in solution, attached to, and inserted across lipid bilayers. Biophys J (2007) 2.06
Energetics of peptide (pHLIP) binding to and folding across a lipid bilayer membrane. Proc Natl Acad Sci U S A (2008) 1.71
Understanding the pharmacological properties of a metabolic PET tracer in prostate cancer. Proc Natl Acad Sci U S A (2014) 1.65
Transmembrane topogenesis of a tail-anchored protein is modulated by membrane lipid composition. EMBO J (2005) 1.57
pK values of the ionizable groups of proteins. Protein Sci (2006) 1.53
Correlation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in metastatic breast carcinoma. Cancer (2000) 1.51
Measuring tumor aggressiveness and targeting metastatic lesions with fluorescent pHLIP. Mol Imaging Biol (2011) 1.50
Interaction of the isolated transmembrane domain of diphtheria toxin with membranes. Biochemistry (1995) 1.47
Effect of cholesterol on structural and mechanical properties of membranes depends on lipid chain saturation. Phys Rev E Stat Nonlin Soft Matter Phys (2009) 1.46
pH (low) insertion peptide (pHLIP) inserts across a lipid bilayer as a helix and exits by a different path. Proc Natl Acad Sci U S A (2010) 1.42
pH-(low)-insertion-peptide (pHLIP) translocation of membrane impermeable phalloidin toxin inhibits cancer cell proliferation. Proc Natl Acad Sci U S A (2010) 1.38
A biophysical study of integral membrane protein folding. Biochemistry (1997) 1.35
Combined kinetic and thermodynamic analysis of alpha-helical membrane protein unfolding. Proc Natl Acad Sci U S A (2007) 1.31
Family of pH (low) insertion peptides for tumor targeting. Proc Natl Acad Sci U S A (2013) 1.31
pH-sensitive membrane peptides (pHLIPs) as a novel class of delivery agents. Mol Membr Biol (2010) 1.29
Bilayer interactions of pHLIP, a peptide that can deliver drugs and target tumors. Biophys J (2008) 1.29
Composition and functions of the influenza fusion peptide. Protein Pept Lett (2009) 1.27
Chiral sum frequency generation spectroscopy for characterizing protein secondary structures at interfaces. J Am Chem Soc (2011) 1.24
Efficient (18)F-labeling of large 37-amino-acid pHLIP peptide analogues and their biological evaluation. Bioconjug Chem (2012) 1.23
pHLIP peptide targets nanogold particles to tumors. Proc Natl Acad Sci U S A (2012) 1.19
Influence of cholesterol on the bilayer properties of monounsaturated phosphatidylcholine unilamellar vesicles. Eur Phys J E Soft Matter (2007) 1.18
The pK(a) values of acidic and basic residues buried at the same internal location in a protein are governed by different factors. J Mol Biol (2009) 1.17
Reversible refolding of the diphtheria toxin T-domain on lipid membranes. Biochemistry (2004) 1.17
[Normal pH value of human skin]. Hautarzt (1986) 1.16
Targeting acidic diseased tissue: New technology based on use of the pH (Low) Insertion Peptide (pHLIP). Chim Oggi (2009) 1.16
Membrane proteins shape up: understanding in vitro folding. Curr Opin Struct Biol (2006) 1.10
Tuning the insertion properties of pHLIP. Biochim Biophys Acta (2009) 1.10
An unfolding story of helical transmembrane proteins. Biochemistry (2006) 1.10
In vivo pH imaging with (99m)Tc-pHLIP. Mol Imaging Biol (2012) 1.09
Chances and pitfalls of cell penetrating peptides for cellular drug delivery. Eur J Pharm Biopharm (2004) 1.09
Accurate analysis of tumor margins using a fluorescent pH Low Insertion Peptide (pHLIP). Int J Mol Sci (2009) 1.07
Targeting pancreatic ductal adenocarcinoma acidic microenvironment. Sci Rep (2014) 1.07
Lipids as a target for drugs modulating multidrug resistance of cancer cells. Curr Drug Targets (2003) 1.06
Cell-penetrating peptides for drug delivery across membrane barriers. Expert Opin Drug Deliv (2008) 1.06
(18)F-labeled-bioorthogonal liposomes for in vivo targeting. Bioconjug Chem (2013) 1.05
Membrane fluidity characteristics of human lung cancer. Cancer Lett (1999) 1.04
Border crossings: colicins and transporters. Annu Rev Genet (2012) 1.02
Roles of carboxyl groups in the transmembrane insertion of peptides. J Mol Biol (2011) 1.02
Modulation of the pHLIP transmembrane helix insertion pathway. Biophys J (2012) 1.01
A transmembrane form of annexin XII detected by site-directed spin labeling. Proc Natl Acad Sci U S A (1998) 1.01
Tuning a polar molecule for selective cytoplasmic delivery by a pH (Low) insertion peptide. Biochemistry (2011) 1.00
Unfolding free energy of a two-domain transmembrane sugar transport protein. Proc Natl Acad Sci U S A (2010) 1.00
pH in human tumour xenografts: effect of intravenous administration of glucose. Br J Cancer (1993) 1.00
Dissecting the membrane binding and insertion kinetics of a pHLIP peptide. Biochemistry (2008) 0.97
pH-controlled delivery of luminescent europium coated nanoparticles into platelets. Proc Natl Acad Sci U S A (2012) 0.96
pH (low) insertion peptide (pHLIP) targets ischemic myocardium. Proc Natl Acad Sci U S A (2012) 0.96
pHLIP®-mediated delivery of PEGylated liposomes to cancer cells. J Control Release (2013) 0.95
Protein self-assembly and lipid binding in the folding of the potassium channel KcsA. Biochemistry (2008) 0.95
Targeting breast tumors with pH (low) insertion peptides. Mol Pharm (2014) 0.94
Reversal of tumor resistance to apoptotic stimuli by alteration of membrane fluidity: therapeutic implications. Adv Cancer Res (2007) 0.94
Membrane fluidity affects tumor-cell motility, invasion and lung-colonizing potential. Int J Cancer (1989) 0.94
Antiproliferative effect of pHLIP-amanitin. Biochemistry (2013) 0.94
Pharmacokinetic considerations for targeted drug delivery. Adv Drug Deliv Rev (2012) 0.93
Widefield optical imaging of changes in uptake of glucose and tissue extracellular pH in head and neck cancer. Cancer Prev Res (Phila) (2014) 0.92
Reversible transition between the surface trimer and membrane-inserted monomer of annexin 12. Biochemistry (2005) 0.91
pH-triggered conformational switching of the diphtheria toxin T-domain: the roles of N-terminal histidines. J Mol Biol (2013) 0.91
pH dependent transfer of nano-pores into membrane of cancer cells to induce apoptosis. Sci Rep (2013) 0.91
Kinetic description of structural changes linked to membrane import of the colicin E1 channel protein. Biochemistry (1999) 0.90
Aspartate embedding depth affects pHLIP's insertion pKa. Biochemistry (2013) 0.90
Folding of outer membrane proteins. Arch Biochem Biophys (2012) 0.88
Cell penetrating peptides and the mechanisms for intracellular entry. Curr Pharm Biotechnol (2014) 0.88
Membrane physical properties influence transmembrane helix formation. Proc Natl Acad Sci U S A (2012) 0.87
Cell membrane fluidity and prognosis of lung cancer. Ann Thorac Surg (2002) 0.87
Comparison of membrane insertion pathways of the apoptotic regulator Bcl-xL and the diphtheria toxin translocation domain. Biochemistry (2013) 0.87
pHLIP-FIRE, a cell insertion-triggered fluorescent probe for imaging tumors demonstrates targeted cargo delivery in vivo. ACS Chem Biol (2014) 0.86
A successful change of circumstance: a transition state for membrane protein folding. Curr Opin Struct Biol (2012) 0.85
Apparent pKa shifts of titratable residues at high denaturant concentration and the impact on protein stability. Biophys Chem (2005) 0.85
Cell-penetrating peptides as a novel transdermal drug delivery system. Chem Biol Drug Des (2012) 0.85
Fluorescence spectroscopy in thermodynamic and kinetic analysis of pH-dependent membrane protein insertion. Methods Enzymol (2009) 0.84
Heterogeneous diffusion of a membrane-bound pHLIP peptide. Biophys J (2010) 0.83
Optical molecular imaging detects changes in extracellular pH with the development of head and neck cancer. Int J Cancer (2012) 0.83
Peptide targeting and imaging of damaged lung tissue in influenza-infected mice. Future Microbiol (2013) 0.80
Effect of temperature on surface properties of cervical tissue homogenate and organic phase monolayers. Colloids Surf B Biointerfaces (2007) 0.78
Bilayer surface association of the pHLIP peptide promotes extensive backbone desolvation and helically-constrained structures. Biophys Chem (2013) 0.77
Membrane binding and insertion of a pHLIP peptide studied by all-atom molecular dynamics simulations. Int J Mol Sci (2013) 0.76